JOURNAL OF NEUROTRAUMA, 2010 · DOI: 10.1089=neu.2009.1069 · Published: March 1, 2010
This study investigates how testosterone, a male hormone, affects the protective effects of 17b-estradiol (E2) after spinal cord injury (SCI) in male rats. The rats were either gonadectomized (testes removed) or left intact, then subjected to SCI and treated with different doses of E2. The study found that E2 is protective in male rats after SCI and that endogenous testosterone does not alter this E2-mediated protection.
The study suggests that 17b-estradiol could be an effective therapeutic intervention for reducing secondary damage after SCI in males, which could be readily translated to clinical trials.
The findings support the clinical relevance of delayed post-SCI administration of 17b-estradiol at doses currently used in clinical practice.
The potential for combined therapies targeting both testosterone and estrogen pathways may offer enhanced neuroprotection strategies after SCI.